<!doctype html><html lang=en><meta charset=utf-8><meta name=generator content="Hugo 0.78.1"><meta name=viewport content="width=device-width,initial-scale=1,viewport-fit=cover"><meta name=color-scheme content="light dark"><meta name=supported-color-schemes content="light dark"><title>Ellinwood 2017&nbsp;&ndash;&nbsp;Papers</title><link rel=stylesheet href=/stevengogogo/PaperNotes/css/core.min.0e6154f1fe5441faaa4f418ca1a607b9f3edbad43b1ab8782737ee279ca2c5a48c8dbe23af3340af50c91a2558bc2b55.css integrity=sha384-DmFU8f5UQfqqT0GMoaYHufPtutQ7Grh4JzfuJ5yixaSMjb4jrzNAr1DJGiVYvCtV><meta name=twitter:card content="summary"><meta name=twitter:title content="Ellinwood 2017"><body><section id=header><div class="header wrap"><span class="header left-side"><a class="site home" href=/stevengogogo/PaperNotes/><span class="site name">Papers</span></a></span>
<span class="header right-side"><div class="nav wrap"><nav class=nav><a class="nav item" href=/stevengogogo/PaperNotes/categories/>Categories</a><a class="nav item" href=/stevengogogo/PaperNotes/tags/>Tags</a></nav></div></span></div><div class="site slogan"><span class=title>Collection of papers I read</span></div></section><section id=content><div class=article-container><section class="article header"><h1 class="article title">Ellinwood 2017</h1><p class="article date">2020-10-22</p></section><article class="article markdown-body"><p><a href=https://sciwheel.com/work/#/items/6117352 target=_blank>Sciwheel</a></p><p><a href=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681918/ target=_blank>Article</a></p><h2 id=introduction>Introduction</h2><ul><li>Atrial fibrillation (AF) is characterized by rapid, irregular heart contractions following fast, disorganized electrical signals in the atria</li><li>most common cardiac arrhythmia (1-2%)</li><li>Pharmacological therapy against AF is limited by low efficacy and substantial adverse side effects including an increased risk of lethal ventricular tachyarrhythmias. radiofrequency ablation is the most effective treatment.</li><li>Genetic mutations causing both loss- and gain-of-function of <strong>IKur</strong> have been associated with atrial arrhythmias in human</li></ul><h2 id=methods>Methods</h2><h3 id=atrial-ap-model-and-simulationss>Atrial AP Model and Simulationss</h3><ul><li>Grandi et al. model</li><li>IKur gating was described by a 6-state Markov type model</li><li>The cycle length (CL) was allowed to vary randomly following a uniform distribution between 285.7 and 400 ms, corresponding to a minimum pacing frequency of 2.5 Hz and a maximum pacing frequency of 3.5 Hz</li><li>The model code is available for download at the following webpages: <a href=https://somapp.ucdmc.ucdavis.edu/Pharmacology/bers/>https://somapp.ucdmc.ucdavis.edu/Pharmacology/bers/</a> and <a href=http://elegrandi.wixsite.com/grandilab/downloads>http://elegrandi.wixsite.com/grandilab/downloads</a> (e-mail required)</li><li>Parameter sensitivity analysis was performed with the population-based approach described in Sobie (2009), Morotti et al. (2017), and Morotti and Grandi (2017)</li></ul><h3 id=kv15-drug-binding-model>KV1.5 Drug-Binding Model</h3><p><img src=https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g002.jpg alt></p><ul><li>dissociation constants (Kd) for our drug scenarios were calculated as koff/kon, and affinity constants were calculated as kon/koff</li></ul><h2 id=results>Results</h2><h3 id=role-of-ikur-in-nsr-and-caf-atrial-electrophysiology>Role of IKur in nSR and cAF Atrial Electrophysiology</h3><p><img src=https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g001.jpg alt></p><ul><li>900 variations of our nSR (normal sinus rhythm) and cAF (chronic AF) human atrial cardiomyocyte models</li><li>At 3-Hz pacing, GKur impacts AP and ERP prolongation more in cAF vs. nSR despite the fact that GKur is smaller in cAF conditions.</li><li>This points to IKur inhibition as a promising approach to counteract the abbreviated APD and ERP in cAF</li></ul><h3 id=effect-of-conformational-state-specificity-and-bindingunbinding-kinetics-on-human-atrial-cardiomyocyte-apd-at-normal-and-fast-pacing-rates-in-caf-conditions>Effect of Conformational State Specificity and Binding/Unbinding Kinetics on Human Atrial Cardiomyocyte APD at Normal and Fast Pacing Rates in cAF Conditions</h3><p><img src=https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g002.jpg alt></p><ul><li>both types of inhibitors display a biphasic relationship between APD and drug-binding kinetics at 1- and 3-Hz pacing</li><li>Significant APD prolongation is only seen for intermediate drug-binding kinetics (0.3–30 s−1 for the open state blocker and 1–30 s−1 for the open and inactivated state blocker)</li><li>At 3-Hz pacing, the two types of inhibitors cause stronger relative prolongation as compared to 1-Hz pacing</li></ul><p><img src=https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g003.jpg alt></p><ul><li>Results in drug-free conditions and for an O & I blocker (modeled as in Figure 2F, black) with kon = koff (Kd = 1 μM) in Figure 3 again demonstrate a biphasic relationship between drug-binding kinetics and average APD90</li></ul><h3 id=effect-of-conformational-state-specificity-and-bindingunbinding-kinetics-on-human-atrial-cardiomyocyte-erp-at-normal-and-fast-pacing-rates-in-caf-conditions>Effect of Conformational State Specificity and Binding/Unbinding Kinetics on Human Atrial Cardiomyocyte ERP at Normal and Fast Pacing Rates in cAF Conditions</h3><p><img src=https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g004.jpg alt></p><ul><li>The desired effect of IKur inhibitors is prolongation of atrial ERP (effective refractory peroid)</li><li>Simulations reveal a similar biphasic relationship between ERP and drug-binding kinetics</li><li>At 1-Hz pacing, IKur inhibitors cause minimal ERP prolongation at slow drug-binding rates (≤0.3 Hz) and fast drug-binding rates (100 Hz)</li><li>ERP prolongation remains ~62 ms lower than the ERP in nSR given no block of IKur for both inhibitors</li><li>At 3-Hz pacing, however, IKur inhibitors appear to be more effective at extending ERP than APD => favorable drug property</li></ul><h3 id=effects-of-drug-bindingunbinding-kinetics-with-variable-kd-on-apd-erp-and-ca2-handling>Effects of Drug Binding/Unbinding Kinetics with Variable Kd on APD, ERP, and Ca2+ Handling</h3><p><img src=https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g005.jpg alt></p><ul><li>Previous figure are for k_on = k_off (Kd = 1)</li><li>Here we simulated all permutations of the nine different rates of drug binding (0.01 to 100 s−1), yielding 81 different combinations of kon and koff for the O & I state inhibitors</li><li>Except for the drugs with the largest Kd values (koff &#187; kon), when kon is held constant, APD, ERP, and Ca2+ handling are not very sensitive to changes in koff. the effects of IKur inhibitors on atrial electrophysiology and Ca2+ handling are largely driven by kon rates as compared to koff rates.</li><li>In cAF conditions, ideal IKur inhibitors exhibiting AF-selectivity will prolong atrial refractoriness (ERP prolongation at 3-Hz pacing), have limited toxicity (minimal to no APD prolongation at 1-Hz pacing), and have a positive inotropic effect (an increase in CaTamp at 1-Hz pacing)</li></ul><h3 id=effect-of-relative-state-specific-drug-binding>Effect of Relative State-Specific Drug Binding</h3><p><img src=https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g006.jpg alt></p><h2 id=discussion>Discussion</h2><ul><li>we sought to determine if IKur is a suitable anti-AF target despite it being downregulated in cAF patients</li><li>we implemented an in silico assessment of IKur inhibitors in cAF atrial cardiomyocyte models, and identified metrics for delineating ideal KV1.5 blockers against AF</li></ul><p><span class=image-container><span class=link><img class=img src=https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g007.jpg alt></span><span class=caption><span class=title>Summary of main findings</span></span></span></p><ul><li>Our simulations suggest that electrophysiological properties in cAF cardiomyocytes, such as shorter AP and more depolarized plateau potential, both might act to increase efficacy and dampen cardiotoxicity of potential KV1.5-targeting drugs as compared to nSR</li></ul><h3 id=ikur-role-in-apd-and-erp-regulation-is-preserved-despite-its-downregulation-in-caf>IKur Role in APD and ERP Regulation Is Preserved Despite Its Downregulation in cAF</h3><ul><li>the consequences of IKur inhibition, including the extent of AP and ERP prolongation, depend not only on IKur magnitude (i.e., maximal conductance), but also on other fluxes affected by AF-induced remodeling</li><li>APD90 and ERP are more sensitive to changes in GKur at fast vs. slow pacing rates</li><li>GKur impacted the duration of AP repolarization and refractoriness more in cAF vs. nSR</li><li>Enhanced Efficacy and Safety of IKur Inhibitors in cAF vs. nSR</li></ul></article><section class="article author"><p class=name>Shao-Ting Chiu</p><div class=details><a class=item href=https://github.com/stevengogogo target=_blank><span class="iconfont icon-github"></span>&nbsp;stevengogogo</a></div></section></div><div class="article bottom"><section class="article navigation"><p><a class=link href=/stevengogogo/PaperNotes/posts/fernandezchas-2018/><span class="iconfont icon-article"></span>Fernandezchas 2018</a></p><p><a class=link href=/stevengogogo/PaperNotes/posts/deoliveira-2016/><span class="iconfont icon-article"></span>Deoliveira 2016</a></p></section></div></section><section id=footer><div class=footer-wrap><p class=copyright>Papers</p><p class=powerby><span>Powered&nbsp;by&nbsp;</span><a href=https://gohugo.io target=_blank>Hugo</a><span>&nbsp;&&nbsp;</span><a href=https://themes.gohugo.io/hugo-notepadium/ target=_blank>Notepadium</a></p></div></section><link rel=stylesheet href=https://cdn.jsdelivr.net/npm/katex@0.11.1/dist/katex.min.css integrity=sha384-zB1R0rpPzHqg7Kpt0Aljp8JPLqbXI3bhnPWROx27a9N0Ll6ZP/+DiW/UqRcLbRjq crossorigin=anonymous><script defer src=https://cdn.jsdelivr.net/npm/katex@0.11.1/dist/katex.min.js integrity=sha384-y23I5Q6l+B6vatafAwxRu/0oK/79VlbSz7Q9aiSZUvyWYIYsd+qj+o24G5ZU2zJz crossorigin=anonymous></script><script defer src=https://cdn.jsdelivr.net/npm/katex@0.11.1/dist/contrib/auto-render.min.js integrity=sha384-kWPLUVMOks5AQFrykwIup5lo0m3iMkkHrD0uJ4H5cjeGihAutqP0yW0J6dpFiVkI crossorigin=anonymous onload=renderMathInElement(document.body);></script></body></html>